English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

It is an honor and a pleasure to participate into this pro/con debate for the TJAR. The invitation from the Chief Editor of TJAR, Prof. Nuzhet Mert Senturck to participate in a PRO/CON debate on use of Hydroxyethylstarch (HES), has been a nice surprise and I immediately accepted. Interestingly, Prof. Nuzhet Mert Senturck, sent to us-Prof. Abreu De Gama as PRO and to myself as CON-a “debate intro” note to address our contribution, where he reports: “The European Medicines Agency (EMA) has advised taking HES off the market. (...) HES’s scientific history is shameful. Can it be possible, that maybe-just maybe-this fact has affected the recommendation of EMA? (...) How do you comment different studies?”

Hydroxyethyl starch: the Paradigm of Eminence-Based Versus Evidence-Based Medicine-1